Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

病例信息患者吕*，男，33岁，主因“发现血肌酐升高3月，周身水肿半月”入院。现病史：患者入院前3月因“原发性血小板减少症”复诊时发现血肌酐升高，为106μmol/L，当时无尿量及尿色改变，无下肢水肿，无恶心、呕吐，无胸闷憋、气，无脱发、光过敏，无皮疹、关节肿痛等，患者未行诊治。入院前半月患者无明显诱因出现周身水 ...

An 80-year-old Brit who found himself in a life-or-death battle with unstoppable bleeding has made a full recovery after ...

Light has long been recognized as a critical regulator of human health, influencing everything from hormone secretion to cardiovascular rhythms. Published in the journal, Journal of Thrombosis and ...

Destination DC (DDC), the official destination marketing organisation for the US capital, has recognised nine industry experts for creating a positive impact in the city and for bringing meetings ...

Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...

Phase 3 FRONTIER3 interim analysis data presented at EAHAD 2025 showed that 74.3% of children on once-weekly Mim8 prophylaxis experienced zero treated ...

24, 2023 — The glycoprotein V of the blood platelets is an important switch point for haemostasis and thrombus formation. This new finding could have great clinical ... Youth Overweight a Risk ...

Tom Nolan reviews this week’s research “Small individual gain, larger population gain” sounds like the theme for a preventive medicine conference. It’s actually the headline of an editorial about a ...

Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...